News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,594 Results
Type
Article (44040)
Company Profile (312)
Press Release (684242)
Multimedia
Podcasts (75)
Webinars (13)
Section
Business (211886)
Career Advice (2098)
Deals (36398)
Drug Delivery (100)
Drug Development (82305)
Employer Resources (176)
FDA (16743)
Job Trends (15329)
News (356191)
Policy (33421)
Tag
Academia (2708)
Accelerated approval (5)
Adcomms (20)
Allergies (90)
Alliances (52481)
ALS (97)
Alzheimer's disease (1408)
Antibody-drug conjugate (ADC) (143)
Approvals (16737)
Artificial intelligence (292)
Autoimmune disease (23)
Automation (17)
Bankruptcy (365)
Best Places to Work (11930)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (221)
Bladder cancer (81)
Brain cancer (27)
Breast cancer (294)
Cancer (2344)
Cardiovascular disease (182)
Career advice (1757)
Career pathing (31)
CAR-T (163)
Cell therapy (451)
Cervical cancer (20)
Clinical research (66878)
Collaboration (894)
Company closure (2)
Compensation (573)
Complete response letters (19)
COVID-19 (2677)
CRISPR (47)
C-suite (260)
Cystic fibrosis (105)
Data (2344)
Decentralized trials (2)
Denatured (31)
Depression (45)
Diabetes (277)
Diagnostics (6648)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (105)
Drug shortages (27)
Duchenne muscular dystrophy (97)
Earnings (88639)
Editorial (39)
Employer branding (22)
Employer resources (151)
Events (117383)
Executive appointments (763)
FDA (18141)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (799)
Gene editing (119)
Generative AI (26)
Gene therapy (328)
GLP-1 (737)
Government (4529)
Grass and pollen (5)
Guidances (156)
Healthcare (19542)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (30)
Infectious disease (2826)
Inflammatory bowel disease (147)
Inflation Reduction Act (8)
Influenza (54)
Intellectual property (102)
Interviews (324)
IPO (16865)
IRA (41)
Job creations (3822)
Job search strategy (1494)
Kidney cancer (10)
Labor market (43)
Layoffs (489)
Leadership (18)
Legal (8129)
Liver cancer (78)
Lung cancer (328)
Lymphoma (159)
Machine learning (9)
Management (62)
Manufacturing (331)
MASH (77)
Medical device (14116)
Medtech (14121)
Mergers & acquisitions (20113)
Metabolic disorders (716)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (95)
Neuropsychiatric disorders (27)
Neuroscience (1966)
NextGen: Class of 2025 (6844)
Non-profit (4618)
Now hiring (40)
Obesity (374)
Opinion (218)
Ovarian cancer (80)
Pain (92)
Pancreatic cancer (89)
Parkinson's disease (152)
Partnered (21)
Patents (251)
Patient recruitment (116)
Peanut (49)
People (59572)
Pharmaceutical (69)
Pharmacy benefit managers (19)
Phase I (20988)
Phase II (29434)
Phase III (21834)
Pipeline (1363)
Policy (149)
Postmarket research (2582)
Preclinical (9014)
Press Release (71)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (266)
Rare diseases (390)
Real estate (6235)
Recruiting (65)
Regulatory (22906)
Reports (47)
Research institute (2459)
Resumes & cover letters (361)
Rett syndrome (6)
RNA editing (5)
RSV (43)
Schizophrenia (72)
Series A (138)
Series B (89)
Service/supplier (15)
Sickle cell disease (54)
Special edition (16)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3844)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (48)
The Weekly (42)
Vaccines (730)
Venture capitalists (43)
Weight loss (243)
Women's health (37)
Worklife (16)
Date
Today (61)
Last 7 days (982)
Last 30 days (3064)
Last 365 days (33229)
2025 (12025)
2024 (36219)
2023 (41136)
2022 (52397)
2021 (56994)
2020 (55612)
2019 (48407)
2018 (36441)
2017 (33541)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (759)
Alabama (55)
Alaska (7)
Arizona (242)
Arkansas (14)
Asia (40561)
Australia (6745)
California (6509)
Canada (2076)
China (550)
Colorado (278)
Connecticut (289)
Delaware (164)
Europe (88820)
Florida (958)
Georgia (223)
Idaho (60)
Illinois (569)
India (26)
Indiana (328)
Iowa (11)
Japan (174)
Kansas (109)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (930)
Massachusetts (4887)
Michigan (246)
Minnesota (413)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (68)
New Hampshire (69)
New Jersey (1820)
New Mexico (28)
New York (1829)
North Carolina (1034)
North Dakota (9)
Northern California (2847)
Ohio (213)
Oklahoma (15)
Oregon (37)
Pennsylvania (1440)
Puerto Rico (14)
Rhode Island (34)
South America (1155)
South Carolina (25)
South Dakota (1)
Southern California (2448)
Tennessee (107)
Texas (961)
United States (24505)
Utah (195)
Virginia (155)
Washington D.C. (65)
Washington State (581)
West Virginia (3)
Wisconsin (59)
728,594 Results for "neonc technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
NeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation
July 16, 2024
·
7 min read
Biotech Beach
NeOnc Technologies Completes $10.0 Million Equity Funding Round
NeOnc Technologies Holdings, Inc., a clinical stage medical biotechnology company, has completed a $10.0 million equity funding round at a post-money valuation of $70 million.
February 8, 2023
·
4 min read
Press Releases
NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug Candidate
August 5, 2024
·
6 min read
Press Releases
NeOnc Initiates Cohort 3 in Phase 1 Clinical Trial of NEO212™, a Patented Novel Hybrid Drug Designed to Deliver ‘Double Punch’ Against Malignant Brain Tumors
July 25, 2024
·
6 min read
Press Releases
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
May 5, 2025
·
5 min read
Press Releases
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology
April 16, 2025
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
·
2 min read
Press Releases
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
March 13, 2025
·
5 min read
Press Releases
FOXO TECHNOLOGIES INC. PROVIDES UPDATE ON ITS BEHAVIORAL HEALTH SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC.
March 12, 2025
·
3 min read
1 of 72,860
Next
